Association of Tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
MetadataShow full item record
Unknown author (2012). Association of Tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'. In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.
This record's URL: http://www.dspace.cam.ac.uk/handle/1810/242143
Rights Holder: et al.; licensee BioMed Central Ltd.